3 Growth Shares For Your Nisa: AstraZeneca plc, Diageo plc And Unilever plc

AstraZeneca plc (LON:AZN), Diageo plc (LON:DGE) and Unilever plc (LON:ULVR) look to be three great growth picks for your new ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At the beginning of this month the much touted New ISA, or Nisa, came into existence.

The Nisa is a revolution for savers. The new product has a limit of £15,000, a substantial increase from the £11,880 allowed in the previous Stocks & Shares ISA. What’s more, you will be able to move freely between shares and cash at any time using the full £15,000 to invest in the stock market, cash or a mix of both.

For those investors who want to add some spice to their Nisa, here are three companies that are set to see their profits surge over the next few years.

Best of both worldsastrazeneca

Recent takeover candidate, AstraZeneca (LSE: AZN) (NYSE: AZN.US) is not only a company with great growth potential, the company’s shares also currently support a 4% dividend yield.

As part of its attempt to rebuff Pfizer, Astra made the claim that the company had the potential to nearly double its annual sales during the next 10 years — from $26 billion today to $45 billion by 2023.

If the company pulls it off, shareholders will be richly rewarded. There is no reason to suggest that the company cannot hit these lofty targets.

Indeed, it is believed that Astra’s current pipeline of oncology treatments is one of the best in the world. The company’s set of AZD9291 cancer treatments is expected to rack up sales of $3 billion, as its flexible nature means that the drug can be combined with other treatments to make several completely different products.

However, at present Astra’s sales are contracting, although current forecasts predict that they will start expanding again during 2016 and 2017. With a dividend yield of 4%, investors will be paid to wait.

Rapid expansion

DiageoDiageo’s (LSE: DGE) (NYSE: DEO.US) growth over the past decade has been nothing short of impressive. Nevertheless, it would appear that the company is just getting started.

Diageo has built itself into the largest alcoholic beverage brand in the world. The company’s drinks cabinet now contains some of the world’s best-known drinks brands including GuinnessSmirnoff vodka and Johnnie Walker whiskey.

Recently the company acquired around 50% of United Spirits, India’s largest spirit company. India’s whiskey consumption doubled during the period 2005 to 2010 and for Diageo, this market has remained largely out of reach.

Strict import laws and tariffs have prevent from Diego from entering the world’s largest whiskey market but control of United Spirits should change that.

Over the long term, Diageo is sure to profit from its Indian expansion.

Emerging marketsUnilever

My final Nisa growth pick is another play on India. Consumer goods giant, Unilever (LSE: ULVR) recently increased its stake in Hindustan Unilever Limited; Unilever’s Indian subsidiary. India is one of the world’s largest consumer markets, so Unilever’s presence within the region is exciting.

Further, Unilever is refocusing its global brand portfolio, selling off non-core, low-margin and low-growth food brands, diverting funds towards the company’s line of home care products. The home care side of the business is actually growing much faster than the food side.

Unilever is a solid pick for income seekers as well. The company currently supports a dividend yield of 3.4%.

Rupert does not own any share mentioned within this article. The Motley Fool owns shares in Unilever. 

More on Investing Articles

Group of friends meet up in a pub
Investing Articles

Are barnstorming Barclays shares still a slam-dunk buy?

Barclays shares have had a blockbuster run but Harvey Jones now questions just how long the FTSE 100 bank can…

Read more »

Close-up of British bank notes
Investing Articles

5 steps to target a £5,000 second income

What would it really take to earn a second income of hundreds of pounds per month from dividend shares? Christopher…

Read more »

Portrait of pensive bearded senior looking on screen of laptop sitting at table with coffee cup.
Investing Articles

Is it madness to bet against the Rolls-Royce share price?

Harvey Jones wonders if the Rolls-Royce share price has flown too high, and it's finally time for investors to stand…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

A once-in-a-decade opportunity to buy quality UK shares?

As some of the UK’s top shares of the last 10 years fall to record low multiples, is this the…

Read more »

Man smiling and working on laptop
Investing Articles

As the FTSE 100 hits record highs, these top shares are still dirt cheap!

The FTSE 100 remains packed with brilliant bargains despite moving to new peaks. Royston Wild picks out two great cheap…

Read more »

UK supporters with flag
Investing Articles

The red-hot FTSE 100 index just did this for the first time ever

The FTSE 100 index has risen in eight out of the past 10 years, and is off to a flying…

Read more »

Growth Shares

Is this FTSE 100 behemoth a no-brainer AI stock?

Some investors bemoan the lack of AI stocks on the FTSE 100. But one surprising Footsie giant is already making…

Read more »

Investing Articles

I asked ChatGPT to create the ultimate £20k Stocks and Shares ISA and it chose…

Harvey Jones wondered what he would put in a Stock and Shares ISA if he was starting to invest from…

Read more »